Back
ESC Premium Access

Risk of upper gastrointestinal bleeding following myocardial infarction: a novel prediction model for assessing appropriateness of proton pump inhibition therapy

Session: New applications of risk assessment in coronary artery disease
Topic: Pharmacotherapy
Speaker: Doctor T. Sehested (Copenhagen, DK)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Thomas Steen Gyldenstierne Sehested

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

5 more presentations in this session

How to improve early prediction of heart failure development after STEMI in clinical arena-is there a place for myocardial deformation imaging?

Speaker: Assistant Professor D. Trifunovic Zamaklar (Belgrade, RS)

Access
Abstract
Slides
Like
Thumbnail

Serial left ventricular global longitudinal strain and mortality in patients with Takotsubo cardiomyopathy

Speaker: Doctor N. Isaza (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Value of GRACE risk score in risk stratification in acute coronary syndrome patients undergoing PCI in the Global Leaders study

Speaker: Doctor Y. Onuma (Galway, IE)

Access
Abstract
Slides
Like
Thumbnail

Prognostic value of the CHADS2 score for adverse cardiovascular events in acute myocardial infarction patients without atrial fibrillation: J-MINUET Substudy

Speaker: Doctor K. Motozato (Kumamoto, JP)

Access
Abstract
Slides
Like
Thumbnail

The CHADS-VASc score is a predictor of No-Reflow in patients with NSTEMI

Speaker: Doctor H. Barman (Istanbul, TR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

New applications of risk assessment in coronary artery disease

Speakers: Doctor T. Sehested, Assistant Professor D. Trifunovic Zamaklar, Doctor N. Isaza, Doctor Y. Onuma, Doctor K. Motozato...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources